Gonadal Hormones and Depression:The Role of Mood Disorder Risk Gene CACNA1C
Gonadal Hormones and Depression:The Role of Mood Disorder Risk Gene CACNA1C
批准号:
8093587
负责人:
Todd D Gould
金额:
$22.5万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-15 至 2013-03-31
关键词:
AdultAllelesAnimal ModelBehaviorBehavioralBiologyBipolar DepressionBipolar DisorderBrainChronicChronic stressCodeDataDevelopmentDiagnosisDiseaseDrug Delivery SystemsEmbryoEstradiolFemaleFunctional disorderFutureGenesGeneticGenetic PolymorphismGenotypeGonadal HormonesGonadal Steroid HormonesHippocampus (Brain)HormonalHormonesHumanHuman GeneticsInterventionKnockout MiceL-Type Calcium ChannelsLeadLearned HelplessnessLong-Term EffectsMajor Depressive DisorderMediatingMental DepressionMeta-AnalysisModelingMolecularMood DisordersMoodsMorphologyMusNeonatalNeuronsNeurosciences ResearchOutcomePatientsPhysiologyPrevention approachProcessReportingResearch PersonnelResistanceRiskRoleSex BiasSex CharacteristicsSingle Nucleotide PolymorphismStressSusceptibility GeneTestingTimeTransgenic MiceTranslatingcohortdisorder riskexperiencegenetic risk factorgenome wide association studygenome-widehuman dataimprovedmalemouse modelnovelpublic health relevanceresearch studyresiliencesextranslational neuroscience
中文摘要
描述(由申请人提供):很明显,性别差异是理解情绪障碍病理生理的关键考虑因素。虽然假设易感基因和激素相互作用可能会改变情绪障碍的发展,但目前支持这一假设的实验证据有限。最近的许多人类遗传研究表明,编码CaV1.2 l型钙通道11亚基的CACNA1C基因多态性与双相情感障碍或抑郁症的诊断存在密切关联。我们最近发现了人类和小鼠的性别差异,这些差异共同表明,CACNA1C基因型主要影响女性对情绪相关行为变化的适应能力,但这些性别差异背后的因素尚不清楚。本应用程序的目的是利用我们的小鼠模型进一步评估性别与Cacna1c基因型之间的相互作用,从而导致抑郁相关行为的发展,并确定在Cacna1c单倍不足小鼠中决定雌性特异性行为影响的激素机制。由于性腺激素介导的组织过程,成人大脑中的性别差异可以在发育早期确立。同样的性腺激素作用于成年人的大脑,它们的作用可能受到早期组织过程的限制,或者可能单独调节生理和行为上的性别差异。我们的中心假设是,性腺激素在新生儿早期组织阶段与Cacna1c基因型相互作用,以调节成年后的抑郁相关行为,Cacna1c表达的降低将导致雌性小鼠对慢性应激的影响具有弹性。我们的具体目标是:1)确定性腺激素的激活作用在Cacna1c单倍功能不全中决定女性特异性学习无助行为的作用;2)确定性腺激素的组织作用在Cacna1c单倍功能不全中决定女性特异性学习无助行为的作用;3)确定慢性不可预测应激抑郁症模型中Cacna1c单倍功能不全与性别在改变行为和脑可塑性方面的相互作用。我们的研究将提高对Cacna1c基因在调节行为和其他大脑功能方面的作用的理解,这与情绪障碍的病理生理有关。完成本应用程序中描述的实验将为性腺激素和遗传风险因素在敏感的发育时期相互作用以调节患情绪障碍的风险的假设提供关键支持。公共卫生相关性:一旦我们完成这些实验,就有可能将我们的发现转化为更多的动物模型,并最终应用于人类,阐明机制和可能的药物靶点,以及对患有情绪障碍和可能携带CACNA1C风险等位基因的患者进行干预的发育时间点。
英文摘要
DESCRIPTION (provided by applicant: It is clear that sex differences are a critical consideration to understanding the pathophysiology of mood disorders. While it is hypothesized as likely that susceptibility genes and hormones interact to modify the development of mood disorders, there exists limited current experimental evidence to support this. Numerous recent human genetic studies indicate a robust association between polymorphisms in CACNA1C, a gene that codes for the 11 subunit of the CaV1.2 L-type calcium channel, and a diagnosis of bipolar disorder or depression. We have recently identified sex differences in both humans and mice, which collectively indicate that CACNA1C genotype influences resilience to mood-related behavioral changes primarily in females, but the factors underlying these sex differences are unknown. The objective of this application is to use our mouse model to further assess the interaction between sex and Cacna1c genotype leading to the development of depression-related behavior, and to define the hormonal mechanisms that determine female-specific behavioral effects in Cacna1c haploinsufficient mice. Sex differences in the adult brain can be established early in development as a result of an organizational process mediated by gonadal hormones. The same gonadal hormones act on the adult brain and their actions may be constrained by earlier organizational processes or may, on their own, mediate sex differences in physiology and behavior. Our central hypothesis is that gonadal hormones interact with Cacna1c genotype during the early neonatal organizational period to modulate depression-related behavior at adulthood, and that decreased expression of Cacna1c will result in female mice that are resilient to the effects of chronic stress. Our specific aims are to: 1) Identify the role of activational effects of gonadal hormones in determining female-specific learned helplessness behavior in Cacna1c haploinsufficiency, 2) Identify the role of organizational effects of gonadal hormones in determining female-specific learned helplessness behavior in Cacna1c haploinsufficiency, and 3) Define the interaction between Cacna1c haploinsufficiency and sex in modifying behavior and brain plasticity in the chronic unpredictable stress model of depression. Our studies will improve understanding of the role of the Cacna1c gene in regulating behavior and other brain functions in a context relevant to the pathophysiology of mood disorders. Completion of the experiments describe in this application will provide critical support for the hypothesis that gonadal hormones and genetic risk factors interact at sensitive developmental time periods to modulate the risk to develop a mood disorder. Public Health Relevance: Once we complete these experiments it will then be possible to translate our findings to additional animal models and ultimately to humans, elucidating mechanisms and possible drug targets, and developmental time points for intervention in patients who suffer from mood disorders and who may carry CACNA1C risk alleles.
PUBLIC HEALTH RELEVANCE: Recent human genetic studies indicate a robust association between polymorphisms in CACNA1C, a gene that codes for the 11 subunit of the CaV1.2 L-type calcium channel, and a diagnosis of bipolar disorder or depression. We have recently identified sex differences in both humans and mice, which collectively indicate that CACNA1C genotype influences mood-related behavioral changes primarily in females, but the factors underlying these sex differences are unknown. Completion of the experiments described in this application will provide critical support for the hypothesis that gonadal hormones and genetic risk factors interact at sensitive developmental time periods to modulate the risk to develop a mood disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estradiol treatment of stress-related psychiatric disorders in Veterans
-
批准号:10484783
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Todd D Gould
-
依托单位:
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
-
批准号:10626710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Todd D Gould
-
依托单位:
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
-
批准号:9561714
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Todd D Gould
-
依托单位:
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
-
批准号:10046271
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Todd D Gould
-
依托单位:
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
-
批准号:10292948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Todd D Gould
-
依托单位:
Targeting the inflammatory response to treat post-traumatic anxiety and depression.
-
批准号:10350545
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:9502214
-
项目类别:
-
资助金额:$15.34万
-
财政年份:2017
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:10553628
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:10056004
-
项目类别:
-
资助金额:$66.67万
-
财政年份:2016
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:10322395
-
项目类别:
-
资助金额:$63.33万
-
财政年份:2016
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:9417095
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2016
-
负责人:Todd D Gould
-
依托单位:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
-
批准号:9314708
-
项目类别:
-
资助金额:$9.24万
-
财政年份:2016
-
负责人:Todd D Gould
-
依托单位:
An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder
-
批准号:8583778
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2013
-
负责人:Todd D Gould
-
依托单位:
Role of Brain Estradiol in the Treatment of Male Depression and Anxiety
-
批准号:8641438
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2013
-
负责人:Todd D Gould
-
依托单位:
Role of Brain Estradiol in the Treatment of Male Depression and Anxiety
-
批准号:8512027
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2013
-
负责人:Todd D Gould
-
依托单位:
An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder
-
批准号:8731972
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2013
-
负责人:Todd D Gould
-
依托单位:
Gonadal Hormones and Depression:The Role of Mood Disorder Risk Gene CACNA1C
-
批准号:8257914
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2011
-
负责人:Todd D Gould
-
依托单位:
Suicide Endophenotypes and Molecular Mechanisms of Lithium Action
-
批准号:8004820
-
项目类别:
-
资助金额:$38.85万
-
财政年份:2010
-
负责人:Todd D Gould
-
依托单位:
Suicide Endophenotypes and Molecular Mechanisms of Lithium Action
-
批准号:8452200
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2010
-
负责人:Todd D Gould
-
依托单位:
Suicide Endophenotypes and Molecular Mechanisms of Lithium Action
-
批准号:8105498
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2010
-
负责人:Todd D Gould
-
依托单位:
海外基金